LPS regulate ERK1/2-dependent signaling in cardiac fibroblasts via PKC-mediated MKP-1 induction

Biochemical and Biophysical Research Communications

Volumn 303, Issue 1, 2003, Pages 74-80

  Stawowy, Philipp ^a   Goetze, Stephan ^a   Margeta, Christian ^a   Fleck, Eckart ^a   Graf, Kristof ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

Author keywords

Angiotensin II; Cardiac fibroblasts; Heart failure; MAP kinase phosphatases; Protein kinases

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; ANTISENSE OLIGODEOXYNUCLEOTIDE; CALPHOSTIN C; DNA; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASES; NUCLEOTIDE; PHOSPHATASE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; UNCLASSIFIED DRUG; 3CH134 PROTEIN; BROXURIDINE; CELL CYCLE PROTEIN; ENZYME INHIBITOR; FLAVONOID; IMMEDIATE EARLY PROTEIN; LIPOSOME; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE;

ANIMAL CELL; ARTICLE; CELL FUNCTION; CHEMOTAXIS; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; FIBROBLAST; HEART FAILURE; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; GENETIC TRANSFECTION; HEART MUSCLE; METABOLISM; PHOSPHORYLATION; PROTEIN BINDING; SPRAGUE DAWLEY RAT; TIME; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL CYCLE PROTEINS; CELL MOVEMENT; CELLS, CULTURED; CHEMOTAXIS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FIBROBLASTS; FLAVONOIDS; IMMEDIATE-EARLY PROTEINS; LIPOPOLYSACCHARIDES; LIPOSOMES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MYOCARDIUM; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C; PROTEIN-TYROSINE-PHOSPHATASE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION;

EID: 0037470864     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)00301-2     Document Type: Article

References (34)

1. Niebauer J., Volk H.D., Kemp M., Dominguez M., Schumann R.R., Rauchhaus M., Poole-Wilson P.A., Coats A.J., Anker S.D. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 353:1999;1838-1842.
2. Delude R.L., Savedra R. Jr., Zhao H., Thieringer R., Yamamoto S., Fenton M.J., Golenbock D.T. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA. 92:1995;9288-9292.
3. Baumgarten G., Knuefermann P., Nozaki N., Sivasubramanian N., Mann D.L., Vallejo J.G. In vivo expression of proinflammatory mediators in the adult heart after endotoxin administration: the role of toll-like receptor-4. J. Infect. Dis. 183:2001;1617-1624.
4. Frantz S., Kobzik L., Kim Y.D., Fukazawa R., Medzhitov R., Lee R.T., Kelly R.A. Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium. J. Clin. Invest. 104:1999;271-280.
5. Yang R.B., Mark M.R., Gray A., Huang A., Xie M.H., Zhang M., Goddard A., Wood W.I., Gurney A.L., Godowski P.J. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature. 395:1998;284-288.
6. Chow J.C., Young D.W., Golenbock D.T., Christ W.J., Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J. Biol. Chem. 274:1999;10689-10692.
7. Weber K.T. Extracellular matrix remodeling in heart failure. A role for de novo angiotensin II generation. Circulation. 96:1997;4065-4082.
8. Hsueh W.A., Law R.E., Do Y.S. Integrins, adhesion, and cardiac remodeling. Hypertension. 31:1998;176-180.
9. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol. Rev. 79:1999;215-262.
10. Schorb W., Booz G., Dostal K., Conrad K., Chang K., Baker K. Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circ. Res. 72:1993;1245-1254.
11. Graf K., Neuss M., Stawowy P., Hsueh W.A., Fleck E., Law R.E. Angiotensin II and α(v)β(3) integrin expression in rat neonatal cardiac fibroblasts. Hypertension. 35:2000;978-984.
12. Xia Z., Dickens M., Raingeaud J., Davis R.J., Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 270:1995;1326-1331.
13. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 9:1995;726-735.
14. Haneda M., Sugimoto T., Kikkawa R. Mitogen-activated protein kinase phosphatase: a negative regulator of the mitogen-activated protein kinase cascade. Eur. J. Pharmacol. 365:1999;1-7.
15. Brondello J.M., Brunet A., Pouyssegur J., McKenzie F.R. The dual specificity mitogen-activated protein kinase phosphatase-1 and -2 are induced by the p42/p44MAPK cascade. J. Biol. Chem. 272:1997;1368-1376.
16. Bueno O.F., De Windt L.J., Lim H.W., Tymitz K.M., Witt S.A., Kimball T.R., Molkentin J.D. The dual-specificity phosphatase MKP-1 limits the cardiac hypertrophic response in vitro and in vivo. Circ. Res. 88:2001;88-96.
17. Sano M., Fukuda K., Sato T., Kawaguchi H., Suematsu M., Matsuda S., Koyasu S., Matsui H., Yamauchi-Takihara K., Harada M., Saito Y., Ogawa S. ERK and p38 MAPK, but not NF-κB, are critically involved in reactive oxygen species-mediated induction of IL-6 by angiotensin II cardiac fibroblasts. Circ. Res. 89:2001;661-669.
18. Iwami K., Ashizawa N., Yung S., Graf K., Hsueh W.A. Comparison of angiotensin II with other growth factors on EGR-1 and matrix gene expression in cardiac fibroblasts. Am. J. Physiol. 270:1996;H2100-2107.
19. Ashizawa N., Graf K., Do Y., Nunohiro T., Giachelli C., Meehan W., Tuan T., Hsueh W.A. Osteopontin is produced by rat cardiac fibroblasts and mediates AII-induced DNA synthesis and collagen gel contraction. J. Clin. Invest. 98:1996;2218-2227.
20. Stawowy P., Blaschke F., Kilimnik A., Goetze S., Kallisch H., Chrétien M., Marcinkiewicz M., Fleck E., Graf K. Proprotein convertase PC5 regulation by PDGF-BB involves PI3-kinase/p70(s6)-kinase activation in vascular smooth muscle cells. Hypertension. 39:2002;399-404.
21. Duff J.L., Monia B.P., Berk B.C. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. Effect of actinomycin D and antisense oligonucleotides. J. Biol. Chem. 270:1995;7161-7166.
22. Graf K., Xi X.P., Yang D., Fleck E., Hsueh W.A., Law R.E. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells. Hypertension. 29:1997;334-353.
23. Valledor A.F., Xaus J., Comalada M., Soler C., Celada A. Protein kinase C epsilon is required for the induction of mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J. Immunol. 164:2000;29-37.
24. Yamakawa T., Eguchi S., Matsumoto T., Yamakawa Y., Numaguchi K., Miyata I., Reynolds C.M., Motley E.D., Inagami T. Intracellular signaling in rat cultured vascular smooth muscle cells: roles of nuclear factor-κB and p38 mitogen-activated protein kinase on tumor necrosis factor-α production. Endocrinology. 140:1999;3562-3572.
25. Ballou L.M., Luther H., Thomas G. MAP2 kinase and 70K S6 kinase lie on distinct signalling pathways. Nature. 349:1991;348-350.
26. Akiyama-Uchida Y., Ashizawa N., Ohtsuru A., Seto S., Tsukazaki T., Kikuchi H., Yamashita S., Yano K. Norepinephrine enhances fibrosis mediated by TGF-β in cardiac fibroblasts. Hypertension. 40:2002;148-154.
27. van Eickels M., Grohe C., Lobbert K., Stimpel M., Vetter H. Angiotensin converting enzyme inhibitors block mitogenic signalling pathways in rat cardiac fibroblasts. Naunyn Schmiedebergs Arch. Pharmacol. 359:1999;394-399.
28. Duff J.L., Marrero M.B., Paxton W.G., Charles C.H., Lau L.F., Bernstein K.E., Berk B.C. Angiotensin II induces 3CH134, a protein-tyrosine phosphatase, in vascular smooth muscle cells. J. Biol. Chem. 268:1993;26037-26040.
29. Li C., Hu Y., Mayr M., Xu Q. Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways. J. Biol. Chem. 274:1999;25273-25280.
30. Keyse S.M. Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr. Opin. Cell Biol. 12:2000;186-192.
31. Takeishi Y., Huang Q., Abe J., Che W., Lee J.D., Kawakatsu H., Hoit B.D., Berk B.C., Walsh R.A. Activation of mitogen-activated protein kinases and p90 ribosomal S6 kinase in failing human hearts with dilated cardiomyopathy. Cardiovasc. Res. 53:2002;131-137.
32. Communal C., Colucci W.S., Remondino A., Sawyer D.B., Port J.D., Wichman S.E., Bristow M.R., Singh K. Reciprocal modulation of mitogen-activated protein kinases and mitogen-activated protein kinase phosphatase 1 and 2 in failing human myocardium. J. Card. Fail. 8:2002;86-92.
33. Lemke L.E., Bloem L.J., Fouts R., Esterman M., Sandusky G., Vlahos C.J. Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPKα is the predominant isoform expressed in human heart. J. Mol. Cell. Cardiol. 33:2001;1527-1540.
34. Yokoyama T., Sekiguchi K., Tanaka T., Tomaru K., Arai M., Suzuki T., Nagai R. Angiotensin II and mechanical stretch induce production of tumor necrosis factor in cardiac fibroblasts. Am. J. Physiol. 276:1999;H1968-H1976.